CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $57,778,000 | +0.9% | 80,106,000 | 0.0% | 1.53% | -37.3% |
| Q2 2022 | $57,276,000 | -2.8% | 80,106,000 | +1.9% | 2.44% | +35.8% |
| Q1 2022 | $58,955,000 | +7.1% | 78,606,000 | +0.6% | 1.79% | -34.1% |
| Q4 2021 | $55,065,000 | +3.1% | 78,106,000 | +7.1% | 2.72% | -33.4% |
| Q3 2021 | $53,429,000 | +13.8% | 72,941,000 | +15.5% | 4.09% | +59.6% |
| Q2 2021 | $46,937,000 | +10.1% | 63,141,000 | +13.4% | 2.56% | -28.6% |
| Q1 2021 | $42,628,000 | +11975.9% | 55,678,000 | +50.4% | 3.59% | +4815.1% |
| Q4 2020 | $353,000 | -98.5% | 37,028,000 | +10.8% | 0.07% | -97.8% |
| Q3 2020 | $23,897,000 | +28.7% | 33,428,000 | +11.7% | 3.32% | +60.9% |
| Q2 2020 | $18,573,000 | +0.7% | 29,934,000 | +5.3% | 2.07% | -30.9% |
| Q1 2020 | $18,447,000 | +30.9% | 28,434,000 | +29.6% | 2.99% | +4.7% |
| Q4 2019 | $14,093,000 | +520.8% | 21,934,000 | +656.3% | 2.86% | +346.2% |
| Q1 2019 | $2,270,000 | -67.7% | 2,900,000 | -71.0% | 0.64% | -86.7% |
| Q4 2018 | $7,029,000 | – | 10,000,000 | – | 4.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Castle Creek Arbitrage, LLC | 3,000,000 | $1,874,000 | 0.49% |
| Opti Capital Management, LP | 4,500 | $2,815,000 | 0.42% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 30,000,000 | $18,578,000,000 | 0.36% |
| CAMDEN ASSET MANAGEMENT L P /CA | 17,336,000 | $10,785,000 | 0.34% |
| CSS LLC/IL | 5,850,000 | $3,650,000 | 0.21% |
| MIZUHO SECURITIES USA LLC | 4,000,000 | $2,504,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 18,750,000 | $11,684,000 | 0.08% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 4,516,000 | $2,834,000 | 0.06% |
| AQR Arbitrage LLC | 7,350,000 | $4,609,000 | 0.05% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 8,000 | $1,562,000 | 0.04% |